Risk factors associated with poor response to COVID-19 vaccination in kidney transplant recipients.
作者信息
Azzi Yorg, Raees Harith, Wang Tao, Cleare Levi, Liriano-Ward Luz, Loarte-Campos Pablo, Pynadath Cindy, Ajaimy Maria, Alani Omar, Bao Yi, Pirofski Liise-Anne, Akalin Enver
机构信息
Division of Nephrology, Montefiore Medical Center Transplant Center, Albert Einstein College of Medicine, Bronx, New York, USA; Department of Abdominal Transplant Surgery, Einstein-Montefiore Abdominal Transplant Center, Bronx, New York, USA.
Department of Abdominal Transplant Surgery, Einstein-Montefiore Abdominal Transplant Center, Bronx, New York, USA.
出版信息
Kidney Int. 2021 Nov;100(5):1127-1128. doi: 10.1016/j.kint.2021.08.019. Epub 2021 Sep 3.
Abstract
摘要
相似文献
1
Risk factors associated with poor response to COVID-19 vaccination in kidney transplant recipients.肾移植受者中与COVID-19疫苗接种反应不佳相关的风险因素。
Kidney Int. 2021 Nov;100(5):1127-1128. doi: 10.1016/j.kint.2021.08.019. Epub 2021 Sep 3.
2
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.血液透析患者和肾移植受者队列中 SARS-CoV-2 mRNA 疫苗接种后的体液反应。
J Am Soc Nephrol. 2021 Sep;32(9):2153-2158. doi: 10.1681/ASN.2021040490. Epub 2021 Jun 16.
3
SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?肾移植受者的新型冠状病毒 2 型疫苗接种：我们是否应考虑皮内接种？
J Am Soc Nephrol. 2022 Apr;33(4):869-870. doi: 10.1681/ASN.2021121566. Epub 2022 Feb 14.
4
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
5
Protection against SARS-CoV-2 Variants with COVID-19 Vaccination in Kidney Transplant Recipients.肾移植受者接种新冠疫苗对SARS-CoV-2变异株的防护作用
Clin J Am Soc Nephrol. 2022 Jan;17(1):3-5. doi: 10.2215/CJN.14881121. Epub 2021 Dec 22.
6
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.血清学反应和抗 SARS-CoV-2 疫苗接种的临床保护作用，以及免疫抑制药物在一组肾移植患者中的作用。
Viruses. 2022 Sep 2;14(9):1951. doi: 10.3390/v14091951.
7
COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.基于mRNA的SARS-CoV-2疫苗接种后肾移植受者发生的新型冠状病毒肺炎
Transpl Infect Dis. 2021 Aug;23(4):e13649. doi: 10.1111/tid.13649. Epub 2021 Jun 13.
8
Authors' Reply: SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?作者回复：肾移植受者中的新型冠状病毒2型疫苗接种：我们是否应考虑皮内接种？
J Am Soc Nephrol. 2022 Apr;33(4):870-871. doi: 10.1681/ASN.2022010033. Epub 2022 Feb 14.
9
Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation.关于改善肾移植受者新冠病毒疫苗接种反应的观察：异源疫苗接种和免疫抑制调节
Kidney Int. 2022 Mar;101(3):642-645. doi: 10.1016/j.kint.2021.11.024. Epub 2021 Dec 8.
10
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.移植前接种疫苗的肾移植受者对 SARS-CoV-2 疫苗保持优越的体液反应。
Clin Transplant. 2021 Dec;35(12):e14478. doi: 10.1111/ctr.14478. Epub 2021 Sep 29.
引用本文的文献
1
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients.免疫抑制方案对泰国肾移植受者接种新冠疫苗后抗体反应的影响。
Heliyon. 2025 Jan 25;11(3):e42291. doi: 10.1016/j.heliyon.2025.e42291. eCollection 2025 Feb 15.
2
SARS-CoV-2-Specific Antibodies, B Cell and T Cell Immune Responses after ChAdOx1 nCoV-19 Vaccination in Solid Organ Transplant Recipients.实体器官移植受者接种ChAdOx1 nCoV-19疫苗后针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的抗体、B细胞和T细胞免疫反应
Vaccines (Basel). 2024 May 15;12(5):541. doi: 10.3390/vaccines12050541.
3
Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.血未结合胆红素和他克莫司是肾移植受者 SARS-CoV-2 灭活疫苗接种后特异性细胞免疫的负预测因子。
Sci Rep. 2023 May 4;13(1):7263. doi: 10.1038/s41598-023-29669-8.
4
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial.研究癌症患者接种第三和第四剂 COVID-19 疫苗的免疫反应效果和持久性：一项单臂临床试验。
Elife. 2023 Mar 28;12:e83694. doi: 10.7554/eLife.83694.
5
Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis.新型冠状病毒疫苗接种后肾移植受者的血清转化率及其与免疫抑制剂的关联：一项系统评价和荟萃分析。
Clin Exp Vaccine Res. 2023 Jan;12(1):13-24. doi: 10.7774/cevr.2023.12.1.13. Epub 2023 Jan 31.
6
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的免疫原性：系统评价和荟萃分析。
Clin Microbiol Infect. 2023 Apr;29(4):441-456. doi: 10.1016/j.cmi.2022.12.004. Epub 2022 Dec 9.
7
SARS-CoV-2-Spike Antibody and T-Cell Responses Elicited by a Homologous Third mRNA COVID-19 Dose in Hemodialysis and Kidney Transplant Recipients.血液透析和肾移植受者中同源第三剂mRNA新冠疫苗引发的SARS-CoV-2刺突抗体和T细胞反应
Microorganisms. 2022 Nov 16;10(11):2275. doi: 10.3390/microorganisms10112275.
8
COVID-19 Vaccination in Kidney Transplant Candidates and Recipients.肾移植候选者和接受者中的新冠病毒疫苗接种
Vaccines (Basel). 2022 Oct 27;10(11):1808. doi: 10.3390/vaccines10111808.
9
Immunogenicity and safety of two-dose SARS-CoV-2 vaccination different platforms in kidney transplantation recipients.两种不同平台的 SARS-CoV-2 疫苗接种在肾移植受者中的免疫原性和安全性。
Front Immunol. 2022 Sep 16;13:951576. doi: 10.3389/fimmu.2022.951576. eCollection 2022.
10
Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的体液和细胞免疫反应：系统评价和荟萃分析。
Transpl Infect Dis. 2022 Dec;24(6):e13926. doi: 10.1111/tid.13926. Epub 2022 Aug 12.
Zotero 插件